The biotech industry's biggest names tend to receive most of the attention. Many smaller players, on the other hand, are just getting warmed up. 

It may only take a few positive clinical updates, regulatory decisions, or a single successful drug to turn a biotech company's fortunes around. For example, consider Moderna. It grew from a $4 billion company into a $59 billion company thanks to the success of its coronavirus vaccine.

Here are two biotech firms that are undervalued today, but have the potential to grow into thriving businesses soon.

Continue reading

Source Fool.com